Viewing Study NCT07156604


Ignite Creation Date: 2025-12-24 @ 9:14 PM
Ignite Modification Date: 2026-01-20 @ 9:10 AM
Study NCT ID: NCT07156604
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-05
First Post: 2025-08-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vebreltinib for Neoadjuvant in METex 14 Skipping Mutant Stage IIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module